Binds cynomolgus and human IgE with similar affinity; does not bind non-primate IgE
“The Cynomolgus monkey was chosen as model to predict human pharmacology and toxicology since omalizumab binds Cynomolgus and human IgE with similar affinity but does not bind non-primate IgE.”
No surrogate; the clinical antibody was tested in cynomolgus monkeys (no non-anaphylactogenic anti-mouse IgE surrogate available)
“Rodent asthma models were not considered because of the species specificity of omalizumab and because there were no appropriate non-anaphylactogenic surrogate antibodies available for evaluation in rodent models.”